CD4+CD56+ lineage negative hematopoietic neoplasm: So called blastic NK cell lymphoma

被引:13
|
作者
Kim, Y
Kang, MS
Kim, CW
Sung, RY
Ko, YH
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea
[2] Soonchunhyang Univ, Cheonan Hosp, Dept Pathol, Cheonan, South Korea
[3] Inje Univ, Pusan, South Korea
[4] Busan Paik Hosp, Pusan, South Korea
[5] Chungbuk Univ, Coll Med, Cheongju, South Korea
关键词
killer cells; natural; lymphoma; blastic NK cell; DNTTIP1; protein; human; receptor-CD3; complex; antigen; T-cell;
D O I
10.3346/jkms.2005.20.2.319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blastic natural killer (NK) cell lymphoma is a rare neoplasm characterized by blastoid tumor cells expressing CD4 and GD56, with predominant skin involvement. Although this tumor has been regarded as a neoplasm related to NK cell, recent studies suggested that it is derived from plasmacytoid dendritic cells, but not from NK cell. Herein we report 4 cases of CD4+CD56+ lineage marker- blastic NK cell lymphomas with a review of literatures. The patients were 3 men and one woman. Three of them were young (17, 18, and 22 yr old). Three patients had skin lesions, at initial presentation in two patients and during the course of disease in other patient. Histologically, tumors consisted of monotonous medium to large blastoid cells showing no necrosis, angiocentric growth or epidermotrophism. All four tumors were CD4+ and CD56+. Three expressed CD68 antigen. Lineage specific markers for B- and T cell were negative. All tumors did not express myeloperoxiclase. T-cell receptor gene rearrangement, EBV, CD13 and CD33 were negative. In one patient, tumor cells arranged in Homer-Wright type pseudorosette and expressed terminal deoxynucleotidyl transferase (TdT). Despite the standard lymphoma chemotherapy, the tumors, except one lost during follow-up, progressed and relapsed. The patients died 8-60 months after diagnosis.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 50 条
  • [21] CD4+CD56+blastic plasmacytoid dendritic Cell Neoplasm- a Case Report
    Mickler, M.
    Rudelius, M.
    Jaeger, T.
    Schreml, S.
    Meier, S.
    Berneburg, M.
    Haferkamp, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 62 - 62
  • [22] Blastic natural killer (NK)-Cell lymphoma: Report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature
    Argyrakos, T
    Rontogianni, D
    Karmiris, T
    Kapsimali, V
    Grigoriou, E
    Tsantekidou, M
    Naum, C
    Galani, V
    Pantelidaki, C
    Harhalakis, N
    Nikiforakis, E
    Kanavaros, P
    LEUKEMIA & LYMPHOMA, 2004, 45 (10) : 2127 - 2133
  • [23] CD4+/CD56+/TdT+ hematodermic neoplasm (previously called blastic natural killer cell lymphoma) in a patient with chronic HTLV-1 infection
    Gurgen, Johnny
    Hogan, Daniel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB95 - AB95
  • [24] Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms) - A review
    Petrella, T
    Bagot, M
    Willernze, R
    Beylot-Barry, M
    Vergier, B
    Delaunay, M
    Meijer, CJLM
    Courville, P
    Joly, P
    Grange, F
    De Muret, A
    Machet, L
    Dompmartin, A
    Bosq, J
    Durlach, A
    Bernard, P
    Dalac, S
    Dechelotte, P
    D'Incan, M
    Wechsler, J
    Teitell, MA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) : 662 - 675
  • [25] The CD4+CD56+neoplasm involves a NK and dendritic cell bipotential precursor.
    Jacob, MC
    Gressin, R
    Plumas, J
    Feuillard, J
    Sotto, JJ
    Bensa, JC
    Chaperot, L
    BLOOD, 1999, 94 (10) : 220B - 220B
  • [26] Fine-needle aspiration cytology of blastic natural killer-cell lymphoma (CD4+ CD56+ hematodermic neoplasm)
    Wu, HHJ
    Ren, RL
    Roepke, JE
    DIAGNOSTIC CYTOPATHOLOGY, 2004, 30 (04) : 268 - 270
  • [27] Blastic plasmacytoid dendritic cell neoplasm or CD4+CD56+acute myeloid leukemia: A case report
    Neji, Sameh
    Ben Lakhal, Fatma
    Salem, Sarra Fekih
    Ghali, Ons
    Ben Neji, Hend
    Achour, Meriem
    El Borgi, Wijdene
    Gouider, Emna
    ANNALES DE BIOLOGIE CLINIQUE, 2024, 82 (04) : 405 - 412
  • [28] CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype
    Urosevic, M
    Conrad, C
    Kamarashev, J
    Asagoe, K
    Cozzio, A
    Burg, G
    Dummer, R
    HUMAN PATHOLOGY, 2005, 36 (09) : 1020 - 1024
  • [29] Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity
    Falcao, RP
    Garcia, AB
    Marques, MG
    Simoes, BP
    Fonseca, BA
    Rodrigues, ML
    Foss, NT
    LEUKEMIA RESEARCH, 2002, 26 (09) : 803 - 807
  • [30] Blastic CD4 NK cell leukemia/lymphoma: A novel clinical entity?
    Falcao, RP
    Garcia, AB
    Marques, MG
    Simoes, BP
    Fonseca, BA
    Rodrigues, ML
    Foss, NT
    Martins, SL
    BLOOD, 2000, 96 (11) : 124A - 124A